These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 35647354)

  • 21. Unveiling the enigma of the blood-brain barrier in glioblastoma: current advances from preclinical and clinical studies.
    Ahmed MH; Canney M; Carpentier A; Thanou M; Idbaih A
    Curr Opin Oncol; 2023 Nov; 35(6):522-528. PubMed ID: 37681417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances and challenges in the molecular biology and treatment of glioblastoma-is there any hope for the future?
    Veliz I; Loo Y; Castillo O; Karachaliou N; Nigro O; Rosell R
    Ann Transl Med; 2015 Jan; 3(1):7. PubMed ID: 25705639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.
    Lefranc F; Rynkowski M; DeWitte O; Kiss R
    Adv Tech Stand Neurosurg; 2009; 34():3-35. PubMed ID: 19368079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An update of advanced nanoplatforms for Glioblastoma Multiforme Management.
    Amaral M; Cruz N; Rosa A; Nogueira B; Costa D; Santos F; Brazão M; Policarpo P; Mateus R; Kobozev Y; Reis CP
    EXCLI J; 2021; 20():1544-1570. PubMed ID: 34924904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vectors for Glioblastoma Gene Therapy: Viral & Non-Viral Delivery Strategies.
    Caffery B; Lee JS; Alexander-Bryant AA
    Nanomaterials (Basel); 2019 Jan; 9(1):. PubMed ID: 30654536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic Monoclonal Antibodies Delivery for the Glioblastoma Treatment.
    Sousa F; Moura RP; Moreira E; Martins C; Sarmento B
    Adv Protein Chem Struct Biol; 2018; 112():61-80. PubMed ID: 29680243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of nanoparticles for drug delivery in glioblastoma multiforme.
    Jain KK
    Expert Rev Neurother; 2007 Apr; 7(4):363-72. PubMed ID: 17425491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intranasal Delivery of Oncolytic Adenovirus XVir-N-31 via Optimized Shuttle Cells Significantly Extends Survival of Glioblastoma-Bearing Mice.
    El-Ayoubi A; Klawitter M; Rüttinger J; Wellhäusser G; Holm PS; Danielyan L; Naumann U
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanomedicine associated with photodynamic therapy for glioblastoma treatment.
    de Paula LB; Primo FL; Tedesco AC
    Biophys Rev; 2017 Oct; 9(5):761-773. PubMed ID: 28823025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene therapy in glioblastoma multiforme: Can it be a role changer?
    Rayati M; Mansouri V; Ahmadbeigi N
    Heliyon; 2024 Mar; 10(5):e27087. PubMed ID: 38439834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced Efficacy of Temozolomide Loaded by a Tetrahedral Framework DNA Nanoparticle in the Therapy for Glioblastoma.
    Fu W; You C; Ma L; Li H; Ju Y; Guo X; Shi S; Zhang T; Zhou R; Lin Y
    ACS Appl Mater Interfaces; 2019 Oct; 11(43):39525-39533. PubMed ID: 31601097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A narrative review of research progress on drug therapies for glioblastoma multiforme.
    Zheng X; Tang Q; Ren L; Liu J; Li W; Fu W; Wang J; Du G
    Ann Transl Med; 2021 Jun; 9(11):943. PubMed ID: 34350258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular Targets and Nanoparticulate Systems Designed for the Improved Therapeutic Intervention in Glioblastoma Multiforme.
    Akhter MH; Rizwanullah M; Ahmad J; Amin S; Ahmad MZ; Minhaj MA; Mujtaba MA; Ali J
    Drug Res (Stuttg); 2021 Mar; 71(3):122-137. PubMed ID: 33167048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current Perspective on the Natural Compounds and Drug Delivery Techniques in Glioblastoma Multiforme.
    Behl T; Sharma A; Sharma L; Sehgal A; Singh S; Sharma N; Zengin G; Bungau S; Toma MM; Gitea D; Babes EE; Judea Pusta CT; Bumbu AG
    Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34199460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanotechnology as a new strategy for the diagnosis and treatment of gliomas.
    Lei J; Huang Y; Zhao Y; Zhou Z; Mao L; Liu Y
    J Cancer; 2024; 15(14):4643-4655. PubMed ID: 39006067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intranasal delivery of stem cell-based therapies for the treatment of brain malignancies.
    Li G; Bonamici N; Dey M; Lesniak MS; Balyasnikova IV
    Expert Opin Drug Deliv; 2018 Feb; 15(2):163-172. PubMed ID: 28895435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Looking for the Holy Grail-Drug Candidates for Glioblastoma Multiforme Chemotherapy.
    Pająk B
    Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel delivery methods bypassing the blood-brain and blood-tumor barriers.
    Hendricks BK; Cohen-Gadol AA; Miller JC
    Neurosurg Focus; 2015 Mar; 38(3):E10. PubMed ID: 25727219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanotechnology and Nanocarrier-Based Drug Delivery as the Potential Therapeutic Strategy for Glioblastoma Multiforme: An Update.
    Hsu JF; Chu SM; Liao CC; Wang CJ; Wang YS; Lai MY; Wang HC; Huang HR; Tsai MH
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33430494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiotherapy for glioblastoma: clinical issues and nanotechnology strategies.
    Li R; Wang H; Liang Q; Chen L; Ren J
    Biomater Sci; 2022 Feb; 10(4):892-908. PubMed ID: 34989724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.